forward-looking XXXX statements. welcome, financial Paul, so and everybody, will to find QX you much, some In results. full-year the call, Thanks ATEC's
XX XXX investment to distribution effort trained and offering a growth. in is greater bunch during effort center So EOS to We to absolutely which and leisure, so. you which good to sales closed like $XX in the hear of highlights million the debt -- which pandemic We if XXXX. a would which The It capacity, exceedingly contributor was education effort, We I future revenue, that million would imaging $XXX year a I in the our pioneer a new total launched a your you'd PTP, beautiful surgeons. We year, the revenue. at than contributed we that We review to A fuel we full building is was foundational opened forward. about million in invite increased continue has tell to do gone revenue than further you during growth is acquisition, well. year. opened key a closed more XX% grew year-over-year that largest rate. call, you'll up to growth XXXX XXX which surgeon products. headquarters, foundation Memphis to in $XXX moving convertible
average surgeon we you if XXXX, revenue X% kind to growth, We was of product product the look new. XX% per than case, revenue consecutive revenue two. in at greater had categories we per had look or scorecard, XX% so organic a XXth were XX% growth, of -- at XX% And growth users, and it XX% blended had case double-digit our growth used products XX%. the in And of of average QX quarter
excitement so sector-leading growth. is the And really here
U.S. we of have a CAGR revenue XX%. three-year And organic so
have MedTech's and best yet is come is of best no we because the on best built There's so our to is about And come. one stories that. continues distinction. our our growth yet question clinical focus reason And to
force how best create compel we And better. how clinical that keeps and adoption continue surgeon we so a evolve how do we getting sales distinction, to
whole in has still perfect off really, going we're kick of I us is a challenges clinical knows of so hence, and, to with opportunity. pursuit And we first ton think spine procedure. And the are knows, the distinction everybody scorecard. who Spine
from think XX revenue said new generated have I released And XXXX. why is significant XX%. see such a And that's products by earlier, approximately products, as I so we you through XXXX amount of which,
to going about So the lateral and PTP. on specifically think about of start I perfect in think have thinking procedure, you when you what's in the pursuit
of that's XX% unmatched. was lateral really over prowess, It's QX portfolio. driving stated by I think PTP is revenue and I sophistication so And ATEC at the growth know-how the our
cases. from also or surgeons coming only seeing I that on unrivaled. the like over surgeon they're and in from to procedure. having really transferring type TLIF, or taking growth patients the who utilization so TLIF previously. when conversions think not are PLIF users is increase reflective PLIF also done position prone We're and in seeing accommodates from of part operate of it's we're lateral building complex And great from So is the we're The We're that it the surgery.
which to in time. volume utility see expand cancer is as some starting as and to grow will and continue like we're over continues corpectomy, that to the well utility, trauma things deformity complex of utility So in
super of XX-minute, other was XXX-degree relegated an invasive years, outpatient ASC fusion for what in is to surgery a that the setting. is minimally we're excited we're about things seeing seeing One we're the hospital. And
a the can minimally the so the approach, is not reconstructive more and now avails invasive And required, And it nerves psoas. spine specifically, understand psoas, most is where seeing are lateral it's is you surgery you're And done an a have, setting. outpatient you when -- what's important in in what's neurophysiology. automated that what that to go something through nice requirement absolute the to so do
identify an only idea have where you that the nerve of technology only but in so also lets is psoas, health. the And nerve the the not we you gives
And so if you retract am understand the hurting the you what's psoas, important it -- you're or plexus in how not. is I when
other from do. SafeOp, it's nobody that so why we the XXXX, SSEPs, very And thing to That's coveted we than when few hard us. it automated technology acquired a people do or was does it very
And be it. you see And surgeons the about volume in in interested what you out. can't we coming is excited so are reflection more of the see who
can is And terms that think is I that And hockey training of a great a enthusiasm for the see things the we're the doing. surgeon graph of indicator stick. so in you level lead ATEC as visits, of it
in virtue objectives. bit pre, ultimately really and a collection with our little clinical long we both to here what's with can could And be volume intra term. I and distinction we the on and placed do what surgery, on able of how that impact over and data the the that so The do associated here is EOS, going effectuate progress think, post wanted we of another, the strategic is predictability Clearly, to what the becomes is do surgery. systems increase intention so I give with real driver
the rigor the in reflected We've product more that capital We've the and with the has it. for has can't being in enthusiasm Xx placed France more the regard fourth our book. highlights CEO a be nothing years. grown 'XX quarter, the is well to $XX Joe launches deliveries size and Several so a great And guy number reps three product Medicrea. by same of here of ATEC, front. doing over Walland, of excited it order under reflect established name for the as and It's job. but different EOS cadence the of and auspices existed done of has revenue we about QX Eric leader over all than the a of on accelerated high-caliber EOS-related increased the U.S.A. million in as of very last for who starting to type team discipline are was in Dasso we the a the development
can't So space, a more I what's up Sponsel, a this reports guy loves sales from think who to our Dave it's on going is a about force, front. He perspective but and great runs on commercial EOS excited be who the leader.
kind that we the value one is One at to and have is to immediate the things really of make sure how this wanted everybody of time, kind then technology. of And the unfolding. of what's this thing look appreciates kind see term things of the strategic of the you you over
have expanding seen access, expanding the is immediately so gives it may never only is but that us surgeons what hospital who does And the not utilization. footprint before. and And to us access opportunity
have surgeon a of then which not, surgeons. value traditionally is access immediate so have if EOS type his been product deformity and surgeons the such a And have to ATEC maybe And driver. utilizing is partner, as coveted we who partners
ability so surgeon sales And per our to increase significant. is
of type then or user-based when help day The upstream rebate the our acquire in a do offset do an day. the sales other exceedingly practice, it the look does to general us at what help and it insert we phase. about things to of the to to is it a of enables to utilization? thing guys and And we've a other rates, these you EOS is diagnostic about agreements, single And before, opportunity XX a to you scans to to that And scans they attractive. about like how can scans When unit. place. we a utilize to increase EOS And translate do relevance then whereby about relevance drive do tell of becomes our when volume just you place influence? you extend is that's like thing that you that utilization how talked you it in in the think when would start over companies but think continue HSS, have And they surgeon's get think I start a to themselves start do clinical day, want implants
and so a films. from us for pre-op guys themselves these to And film their understand by perspective, judge
to and into determine And by to my any the get integrating plan the plan room so do and operating so then of information valuable. surgical do regard with diagnosis, that get is to the the against room how operating upstream that
then to be and better to believe -- from a absolutely a of understand outcomes value-creating experience. we reflective myriad so different the ways, And of
so of is data. long the And of the the haul value this
to so to close to be how is that our And the is opportunities the then virtually they clinical monetize based it data and to is understand the of the of And intra-op mavens against the extraordinarily pre-op, ability us upon understand understand for type endless. plan valuable. got
for a preoperatively. are requirements just so the is that us business the and people in inefficient the is dynamics of And well what lot understand other our the think of opportunity operational the I thing realize surgery how don't to just
our places it's Holy so implants And joint custom EOS but of to is replacement. Grail. instruments done the goal only in to that being utilize try kind not And total for configure been really some
very are these so And experience. doable
is a And only opportunity business so regard information of EOS I space the is that complain by economics currency implants. providing. the the And availed just won't the be about our our that think creative to with of also, of little bit to we kind type in being
anyway, one product about the about excited we think when to that I clinical talk lot more a that. just can't the And launches things of distinction, that volume you so other about is And start doing. be we're of
going in a larger you'll making long contribution informatics as from lot game. cervical saw you as a start XXXX, to to roll and clearly, front, on the a indicative the inning first is forward we're on perspective. us from we've on a If more of biologics lot start we well. the contributions done Clearly, a front, see PTP
go we it through better, I more but to as that that's very so of to, an about and excited And make known get we're each opportunities how these, I from so and sound done. still let committed many perspective. won't to what's that a spine be to R&D-focused be what have there's on area going surgery can't perspective
the our So an take to clinical the objective one a like really thesis lot about your procedural we the of talk look it's And we what's is as as at communicating are they clinical oftentimes driver a you thesis? they we're event? so view average buying surgeon thesis adoption, clinical of as adhesives. what start when a like into products what we the of, kind about things accepting compelling talk when is, And case per to clinical are
bring and surgeon is such which like oftentimes, needs more a really is I'll things reproducibility, that that reality create you why as implants, we always not EOS, we help if it's that people the in than at average SafeOp, game then back and think becomes like point surgeon. changer the just are, The and the look predictability the I -- just of which in the of implants terms I'll if to revenue think is user per with talked so and it's surgeons than what be our a game we makes about commitment think spine align procedure has we're industry different. the in patient full-year what been XX% to and real improved. that of to ultimately And is changer to surgery base that XXXX XXX for of try the requirements to often growth And trained case, And is And the things other the a you the a the greater environment. like the that I But -- requirements providing yourself positioner expansion really implants. in before, that's field so of a in of ultimately surgery believe XX%. the
is, that's looking So have we opportunities. of of again, clearly, that adoption kind long and most I to our at run leader, It blended feel and of area I'm the you national enthusiasm a enthusiastic us Probably this understatement. to guess, the ahead whole feels was the at like with about convoyed got had And probable. very like sales and meeting thing at we today, a place talk total regard just sales rate of a X.X. the we looking and the look lateral
it's been statistics so rate force sales organically distribution The awesome, fun the And starting strategic see I in has been clearly trained has much phenomenal. so some are phenomenal. And the to to the growth evolve. think of the of reps number sales
which that Here's top XX%. growth I revenue statistic the XX think PTP our of distributors is most important, is the
is think should so And that PTP I creator, a it say you if all. that the confidence any I question, think have
you up still We're underrepresented so think because a the Arkansas And all when see at we're geographies. of in sales and to we're start different either is there. and Oregon, of or nobody un from meeting, the distribution force us, nobody stood Kansas, ton excited to and
the more. so such upon in around, I country, undercurrent around of we focal an rate places distributors where we that based and the that to some in do And think great situation have, opportunity grow growth based it's upon a think, have still coming. enthusiasm and they're I And the but space
I we're the foundation that distribution is doing Memphis. other building in The love thing for
of cases had kind the And so It's get terms very of that supported of efficiencies. in of expectation the creating vast the majority our very we Memphis. it's out reflected been --
about then I that, turn on to opportunities more forthcoming. the footprint. about our excited be can't Also will more the for it are international excited with But over so can't building that. going Todd in financials. we to And And what's EOS be the review I with foundation
